<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Our study assessed three outcomes as follows: baseline CD4+ cell count at the time of diagnosis, mortality before ART (ART-na√Øve status), and mortality after ART (ART status).</p>
